{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:12:03Z","timestamp":1793329923314,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ahj.2016.02.020","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T10:30:33Z","timestamp":1458210633000},"page":"28-35","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"special_numbering":"C","title":["Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial"],"prefix":"10.1016","volume":"176","clinical-trial-number":[{"clinical-trial-number":"nct01331707","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Liefke C.","family":"van der Heijden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlies M.","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Danse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marije M.","family":"L\u00f6wik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C.M.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Stoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine J.M.","family":"Doggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"von Birgelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2016.02.020_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0735-1097(99)00181-3","article-title":"Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization","volume":"34","author":"Schunkert","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0010","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1161\/01.CIR.98.18.1875","article-title":"Vessel size and long-term outcome after coronary stent placement","volume":"98","author":"Elezi","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.02.020_bb0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.carrev.2009.04.007","article-title":"Percutaneous coronary intervention for small vessel coronary artery disease","volume":"11","author":"Biondi-Zoccai","year":"2010","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.ahj.2016.02.020_bb0020","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0735-1097(98)00444-6","article-title":"Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels","volume":"32","author":"Akiyama","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0025","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/eurheartj\/ehi116","article-title":"Is bare-metal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials","volume":"26","author":"Agostoni","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.02.020_bb0030","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S0735-1097(98)00404-5","article-title":"Angiographic and intravascular ultrasound predictors of in-stent restenosis","volume":"32","author":"Kasaoka","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0035","first-page":"94","article-title":"Two-year clinical outcome after coronary stenting of small vessels using 2.25-mm sirolimus- and paclitaxel-eluting stents: insight into the RESEARCH end T-SEARCH registries","volume":"69","author":"Tanimoto","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0040","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"11","author":"Claessen","year":"2011","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0045","first-page":"207","article-title":"Two-year safety and effectiveness of the platinum chromium everolimus-eluting stent for the treatment of small vessels and longer lesions","volume":"85","author":"Teirstein","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0050","first-page":"60","article-title":"An everolimus-eluting stent versus a paclitaxel-eluting stent in small vessel coronary artery disease: a pooled analysis from the SPIRIT II and SPIRIT III trials","volume":"76","author":"Bartorelli","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jjcc.2013.10.016","article-title":"Clinical outcomes of everolimus- and zotarolimus eluting stents in patients with acute myocardial infarction for small coronary artery disease","volume":"63","author":"Cho","year":"2014","journal-title":"J Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0060","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2007.06.015","article-title":"Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents","volume":"50","author":"Togni","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2004.01.024","article-title":"The Canadian study of sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)","volume":"43","author":"Schampaert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0070","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.ahj.2011.07.024","article-title":"Long-term clinical outcome in patients with small vessel disease treated with drug-eluting versus bare-metal stenting","volume":"162","author":"Puyrimat","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.02.020_bb0075","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.292.22.2727","article-title":"Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial","volume":"292","author":"Ardissino","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2016.02.020_bb0080","first-page":"192","article-title":"Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry","volume":"83","author":"Parikh","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0085","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1161\/CIRCULATIONAHA.104.513952","article-title":"Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison","volume":"111","author":"Mauri","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.02.020_bb0090","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1161\/01.CIR.103.23.2816","article-title":"Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial","volume":"103","author":"Kastrati","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.02.020_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0735-1097(02)01989-7","article-title":"In-stent restenosis in small coronary arteries: impact of strut thickness","volume":"40","author":"Briguori","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0100","first-page":"7","article-title":"Clinical outcomes in real-world patients with small vessel disease treated with Xience V everolimus-eluting stents: one year results from the Xience V USA condition of approval post-market study","volume":"84","author":"Hermiller","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0105","first-page":"17","article-title":"Performance of the Resolute Zotarolimus\u2013eluting stent in small vessels","volume":"84","author":"Caputo","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0110","first-page":"216","article-title":"Small vessel and long lesions: changing label indications for drug eluting stents","volume":"85","author":"Srour","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(13)62037-1","article-title":"Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial","volume":"383","author":"von Birgelen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2016.02.020_bb0120","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jcin.2015.01.033","article-title":"Clinical events and patient-reported chest pain in all-comers treated with Resolute Integrity and Promus Element stents: two-year follow-up of the randomized DUTCH PEERS (TWENTE II) trial","volume":"8","author":"Sen","year":"2015","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0125","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ahj.2012.02.001","article-title":"Durable polymer-based sTent Challenge of promus ElemEnt versus ReSolute integrity (DUTCH PEERS): rationale and study design of a randomized multicenter trial in a Dutch all-comers population","volume":"163","author":"Tandjung","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.02.020_bb0130","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.02.020_bb0135","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2016.02.020_bb0140","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.jacc.2006.05.068","article-title":"Vessel size and outcome after coronary drug-eluting stent placement: results from a large cohort of patients treated with sirolimus- or pacliaxel-eluting stents","volume":"48","author":"Elezi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0145","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jcin.2009.05.024","article-title":"Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer: the LEADERS trial substudy","volume":"2","author":"Wykrzykowska","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.CIR.86.1.232","article-title":"Lumen diameter of normal human coronary arteries: influence of age, sex, anatomic variation, and left ventricular hypertrophy or dilation","volume":"86","author":"Dodge","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.02.020_bb0155","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2008.03.051","article-title":"Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials","volume":"52","author":"Nicholls","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.02.020_bb0160","first-page":"341-22","article-title":"Acute and long-term outcomes of stenting in coronary vessel >3.0 mm, 3.0-2.5 mm, and <2.5 mm","volume":"53","author":"Hsieh","year":"2001","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0165","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jcin.2012.08.005","article-title":"Paclitaxel drug-coated balloons: a review of current status and emerging applications in native coronary artery de novo lesions","volume":"5","author":"Loh","year":"2012","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.ahj.2016.02.020_bb0170","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/heartjnl-2013-304881","article-title":"Prospective \u2018real world\u2019 registry for the use of the \u2018PCB only\u2019 strategy in small vessel de novo lesions","volume":"100","author":"Zeymer","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2016.02.020_bb0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/hrt.79.2.137","article-title":"Atherosclerotic coronary lesions with inadequate compensatory enlargement have smaller plaque and vessel volumes: observations with three dimensional intravascular ultrasound in vivo","volume":"79","author":"von Birgelen","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2016.02.020_bb0180","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0002-9149(96)00356-6","article-title":"Quantification of the minimal luminal cross-sectional area after coronary stenting by two- and three-dimensional intravascular ultrasound versus edge detection and vidodensitometry","volume":"78","author":"von Birgelen","year":"1996","journal-title":"Am J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:56:33Z","timestamp":1757570193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":36,"alternative-id":["S0002870316000867"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.02.020","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.02.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}